Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Leukemia

  Free Subscription


30.12.2024

1 Am J Hematol
1 Ann Hematol
6 Blood
1 BMC Cancer
1 Cancer Chemother Pharmacol
1 Cancer Lett
3 Eur J Haematol
3 Int J Hematol
1 J Pediatr Hematol Oncol
2 Leuk Lymphoma
2 Leuk Res
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. SENAPATI J, Kantarjian HM, Haddad FG, Short NJ, et al
    Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation.
    Am J Hematol. 2024 Dec 24. doi: 10.1002/ajh.27561.
    PubMed         Abstract available


    Ann Hematol

  2. ZHAO Y, Yu X, Yan L, Shi D, et al
    Study on clinical features of early death in older patients with acute promyelocytic leukemia.
    Ann Hematol. 2024 Dec 27. doi: 10.1007/s00277-024-06165.
    PubMed         Abstract available


    Blood

  3. CRUZ-RODRIGUEZ N, Deininger MW
    Novel Treatment Strategies for Chronic Myeloid Leukemia.
    Blood. 2024 Dec 27:blood.2024026312. doi: 10.1182/blood.2024026312.
    PubMed         Abstract available

  4. NAHARRO EF, Linden MA
    Auer rod-like inclusions in B-cell lymphoma mimicking therapy-related acute myeloid leukemia.
    Blood. 2024;144:2793.
    PubMed        

  5. HULS GA, Woolthuis CM, Schuringa JJ
    Menin inhibitors in the treatment of acute myeloid leukemia.
    Blood. 2024 Dec 24:blood.2024026232. doi: 10.1182/blood.2024026232.
    PubMed         Abstract available

  6. ARONS E, Tai CH, Suraj J, Liu Y, et al
    Non-V600E BRAF mutations and treatment for Hairy Cell Leukemia.
    Blood. 2024 Dec 24:blood.2024026894. doi: 10.1182/blood.2024026894.
    PubMed         Abstract available

  7. LACHOWIEZ CA, Ravikumar VI, Othman J, O'Nions J, et al
    Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML.
    Blood. 2024;144:2788-2792.
    PubMed         Abstract available

  8. BROWN JR, Eichhorst B, Lamanna N, O'Brien SM, et al
    Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE.
    Blood. 2024;144:2706-2717.
    PubMed         Abstract available


    BMC Cancer

  9. LI P, Liu L, Zhou F
    A distinct subgroup of AML resembling the APL immunophenotype is associated with DIC.
    BMC Cancer. 2024;24:1576.
    PubMed         Abstract available


    Cancer Chemother Pharmacol

  10. MANGOURA SA, Abdel-Raheem MH, Eltyb HA, Molla MS, et al
    Influence of CYP2C8*3 and ABCG2 C421A genetic polymorphisms on trough concentration and molecular response of imatinib in Egyptian patients with chronic myeloid leukemia.
    Cancer Chemother Pharmacol. 2024;95:12.
    PubMed         Abstract available


    Cancer Lett

  11. JIN P, Shen J, Zhao M, Yu J, et al
    Driver mutation landscape of acute myeloid leukemia provides insights for neoantigen-based immunotherapy.
    Cancer Lett. 2024 Dec 24:217427. doi: 10.1016/j.canlet.2024.217427.
    PubMed         Abstract available


    Eur J Haematol

  12. ROWE M, Babushok D, Carroll M, Carulli A, et al
    Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.
    Eur J Haematol. 2024 Dec 26. doi: 10.1111/ejh.14371.
    PubMed         Abstract available

  13. TANG MW, Van der Tuin D, Aydin M, Heijmans J, et al
    Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome.
    Eur J Haematol. 2024 Dec 26. doi: 10.1111/ejh.14370.
    PubMed         Abstract available

  14. PUCKRIN R, Owen C, Peters A
    Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic Leukemia.
    Eur J Haematol. 2024 Dec 27. doi: 10.1111/ejh.14376.
    PubMed         Abstract available


    Int J Hematol

  15. UTSUNOMIYA A, Yasunaga JI, Tabuchi T, Nakano N, et al
    A 25-year clonal resurrection in adult T-cell leukemia-lymphoma relapse.
    Int J Hematol. 2024 Dec 25. doi: 10.1007/s12185-024-03901.
    PubMed         Abstract available

  16. FUJITA H
    Correction: JSH practical guidelines for hematological malignancies, 2023: leukemia-2-acute promyelocytic leukemia (APL).
    Int J Hematol. 2024 Dec 24. doi: 10.1007/s12185-024-03908.
    PubMed        

  17. MAEDA Y
    Correction: JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML).
    Int J Hematol. 2024 Dec 24. doi: 10.1007/s12185-024-03907.
    PubMed        


    J Pediatr Hematol Oncol

  18. MILLER DR
    Contributions of Pediatric Hematology/Oncology to the Diagnosis, Treatment, and Cure of Acute Lymphoblastic Leukemia: Part 2a (Numbers 11 to 15).
    J Pediatr Hematol Oncol. 2024 Dec 16. doi: 10.1097/MPH.0000000000002960.
    PubMed         Abstract available


    Leuk Lymphoma

  19. GUGLIELMANA V, Rossi D
    Prognostic and predictive impact of NOTCH1 mutation in chronic lymphocytic leukemia: a systematic review.
    Leuk Lymphoma. 2024 Dec 27:1-10. doi: 10.1080/10428194.2024.2441858.
    PubMed         Abstract available

  20. NILSSON MS, Martner A, Wennstrom L, Hansson M, et al
    Consistency of the efficacy of immunotherapy with histamine dihydrochloride and low-dose interleukin-2 for relapse prevention in acute myeloid leukemia.
    Leuk Lymphoma. 2024 Dec 24:1-3. doi: 10.1080/10428194.2024.2444466.
    PubMed        


    Leuk Res

  21. SHAHZAD M, Iqbal Q, Amin MK, Irfan S, et al
    Outcomes of hematopoietic stem cell transplantation in primary plasma cell leukemia: A systematic review and meta-analysis.
    Leuk Res. 2024;148:107640.
    PubMed         Abstract available

  22. LI J, Fu S, Ye C, Li J, et al
    Combination therapy involving azacitidine for acute myeloid leukemia patients ineligible for intensive chemotherapy.
    Leuk Res. 2024;148:107638.
    PubMed         Abstract available


    PLoS One

  23. TANG D, Wang H, Jiang Y, Chen M, et al
    ATRA-induced NEAT1 upregulation promotes autophagy during APL cell granulocytic differentiation.
    PLoS One. 2024;19:e0316109.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.